Skip to main content
Erschienen in: International Urology and Nephrology 8/2020

19.03.2020 | Urology - Original Paper

The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan

verfasst von: Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama

Erschienen in: International Urology and Nephrology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We investigated the gut microbiome in subjects with erectile dysfunction (ED) in a community-based population.

Methods

This cross-sectional study surveyed comprehensive health status in 408 men who participated in the Iwaki Health Promotion Project in 2015 in Hirosaki, Japan. The gut microbiome was assessed by tag sequencing of the 16S rRNA gene, which we extracted from fecal samples. Erectile function was evaluated with the five-item International Index of Erectile Function (IIEF-5), and the men were divided into two groups: low-IIEF-5 (≤ 16) and high-IIEF-5 (> 16). Of those, we selected age-adjusted 192 men (96 each) for analysis. We investigated the association of gut microbiome with IIEF-5 between the two groups.

Results

Median age was 50 years. No significant difference was seen in the history of hypertension, DM, CKD, and CVD between the low-IIEF-5 and high-IIEF-5 groups. However, the relative abundance of Alistipes (related with anti-inflammation) and Clostoridium XVIII (related with bowel movement) was significantly different between the two groups. Multivariate logistic analysis demonstrated that the relative abundance of Clostridium XVIII (OR, 2.06; 95% CI, 1.20–3.55, P = 0.009) and Alistipes (OR, 0.81; 95% CI, 0.66–0.99, P = 0.040) and, with an IPSS ≥ 8, were independent factors for low IIEF-5.

Conclusion

We observed significant association between the low-IIEF-5 and high-IIEF-5 groups in Alistipes and Clostoridium XVIII. Further study is necessary to access the causal relationship between the gut microbiome and ED.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Otoole PW, Jeffery IB (2015) Gut microbiota and aging. Science (80-) 350:1214–1215 Otoole PW, Jeffery IB (2015) Gut microbiota and aging. Science (80-) 350:1214–1215
2.
Zurück zum Zitat Barlow GM, Yu A, Mathur R (2015) Role of the gut microbiome in obesity and diabetes mellitus. Nutr Clin Pract 30:787–797PubMed Barlow GM, Yu A, Mathur R (2015) Role of the gut microbiome in obesity and diabetes mellitus. Nutr Clin Pract 30:787–797PubMed
3.
Zurück zum Zitat Yin J, Liao S-X, He Y, Wang S, Xia G-H, Liu F-T et al (2015) Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc 4:e002699PubMedPubMedCentral Yin J, Liao S-X, He Y, Wang S, Xia G-H, Liu F-T et al (2015) Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc 4:e002699PubMedPubMedCentral
4.
Zurück zum Zitat Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G et al (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5:14PubMedPubMedCentral Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G et al (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5:14PubMedPubMedCentral
5.
Zurück zum Zitat Kanbay M, Onal EM, Afsar B, Dagel T, Yerlikaya A, Covic A et al (2018) The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Int Urol Nephrol 50:1453–1466PubMed Kanbay M, Onal EM, Afsar B, Dagel T, Yerlikaya A, Covic A et al (2018) The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus. Int Urol Nephrol 50:1453–1466PubMed
6.
Zurück zum Zitat Li N, Wang X, Sun C, Wu X, Lu M, Si Y et al (2019) Change of intestinal microbiota in cerebral ischemic stroke patients. BMC Microbiol 19:191PubMedPubMedCentral Li N, Wang X, Sun C, Wu X, Lu M, Si Y et al (2019) Change of intestinal microbiota in cerebral ischemic stroke patients. BMC Microbiol 19:191PubMedPubMedCentral
7.
Zurück zum Zitat Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L (2016) Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 7:979PubMedPubMedCentral Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L (2016) Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 7:979PubMedPubMedCentral
8.
Zurück zum Zitat van den Munckhof ICL, Kurilshikov A, Ter Horst R, Riksen NP, Joosten LAB, Zhernakova A et al (2018) Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies. Obes Rev 19:1719–1734PubMed van den Munckhof ICL, Kurilshikov A, Ter Horst R, Riksen NP, Joosten LAB, Zhernakova A et al (2018) Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies. Obes Rev 19:1719–1734PubMed
9.
Zurück zum Zitat Walker A, Pfitzner B, Harir M, Schaubeck M, Calasan J, Heinzmann SS et al (2017) Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat diets. Sci Rep 7:11047PubMedPubMedCentral Walker A, Pfitzner B, Harir M, Schaubeck M, Calasan J, Heinzmann SS et al (2017) Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat diets. Sci Rep 7:11047PubMedPubMedCentral
10.
Zurück zum Zitat Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J et al (2017) New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5:24PubMedPubMedCentral Strati F, Cavalieri D, Albanese D, De Felice C, Donati C, Hayek J et al (2017) New evidences on the altered gut microbiota in autism spectrum disorders. Microbiome 5:24PubMedPubMedCentral
11.
Zurück zum Zitat Zhang Z, Li H, Zhang X, Dai Y, Park HJ, Jiann B et al (2019) Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled s. Int J Urol 26:192–200PubMed Zhang Z, Li H, Zhang X, Dai Y, Park HJ, Jiann B et al (2019) Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-controlled s. Int J Urol 26:192–200PubMed
12.
Zurück zum Zitat Okamoto T, Hatakeyama S, Imai A, Konishi S, Okita K, Yamamoto H et al (2019) The relationship between gait function and erectile dysfunction: results from a community-based cross-sectional study in Japan. J Sex Med 16:1922–1929PubMed Okamoto T, Hatakeyama S, Imai A, Konishi S, Okita K, Yamamoto H et al (2019) The relationship between gait function and erectile dysfunction: results from a community-based cross-sectional study in Japan. J Sex Med 16:1922–1929PubMed
13.
Zurück zum Zitat Cao S, Gan Y, Dong X, Liu J, Lu Z (2014) Association of quantity and duration of smoking with erectile dysfunction: a dose-response meta-analysis. J Sex Med 11:2376–2384PubMed Cao S, Gan Y, Dong X, Liu J, Lu Z (2014) Association of quantity and duration of smoking with erectile dysfunction: a dose-response meta-analysis. J Sex Med 11:2376–2384PubMed
14.
Zurück zum Zitat Kałka D, Domagała Z, Dworak J, Womperski K, Rusiecki L, Marciniak W et al (2013) Association between physical exercise and quality of erection in men with ischaemic heart disease and erectile dysfunction subjected to physical training. Kardiol Pol 71:573–580PubMed Kałka D, Domagała Z, Dworak J, Womperski K, Rusiecki L, Marciniak W et al (2013) Association between physical exercise and quality of erection in men with ischaemic heart disease and erectile dysfunction subjected to physical training. Kardiol Pol 71:573–580PubMed
15.
Zurück zum Zitat Calogero AE, Burgio G, Condorelli RA, Cannarella R, La Vignera S (2019) Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male 22:12–19PubMed Calogero AE, Burgio G, Condorelli RA, Cannarella R, La Vignera S (2019) Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male 22:12–19PubMed
16.
Zurück zum Zitat Malavige LS, Levy JC (2009) Erectile dysfunction in diabetes mellitus. J Sex Med 6:1232–1247PubMed Malavige LS, Levy JC (2009) Erectile dysfunction in diabetes mellitus. J Sex Med 6:1232–1247PubMed
17.
Zurück zum Zitat Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F et al (2010) Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis 56:670–685PubMed Navaneethan SD, Vecchio M, Johnson DW, Saglimbene V, Graziano G, Pellegrini F et al (2010) Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies. Am J Kidney Dis 56:670–685PubMed
18.
Zurück zum Zitat Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 151:54–61PubMed Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 151:54–61PubMed
19.
Zurück zum Zitat Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S (2005) Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 48:512–518PubMed Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S (2005) Is erectile dysfunction an indicator for increased risk of coronary heart disease and stroke? Eur Urol 48:512–518PubMed
20.
Zurück zum Zitat Fode M, Sønksen J (2014) Sexual function in elderly men receiving androgen deprivation therapy (ADT). Sex Med Rev 2:36–46PubMed Fode M, Sønksen J (2014) Sexual function in elderly men receiving androgen deprivation therapy (ADT). Sex Med Rev 2:36–46PubMed
21.
Zurück zum Zitat Schauer I, Keller E, Müller A, Madersbacher S (2015) Have rates of erectile dysfunction improved within the past 17 years after radical prostatectomy? A systematic analysis of the control arms of prospective randomized trials on penile rehabilitation. Andrology 3:661–665PubMed Schauer I, Keller E, Müller A, Madersbacher S (2015) Have rates of erectile dysfunction improved within the past 17 years after radical prostatectomy? A systematic analysis of the control arms of prospective randomized trials on penile rehabilitation. Andrology 3:661–665PubMed
22.
Zurück zum Zitat Pinkawa M, Gagel B, Piroth MD, Fischedick K, Asadpour B, Kehl M et al (2009) Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 55:227–236PubMed Pinkawa M, Gagel B, Piroth MD, Fischedick K, Asadpour B, Kehl M et al (2009) Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 55:227–236PubMed
23.
Zurück zum Zitat Okihara K, Yorozu A, Saito S, Tanaka N, Koga H, Higashide S et al (2017) Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: analysis from the Japanese prostate cancer outcome study of permanent iodine-125 seed implantation database. Int J Urol 24:518–524PubMed Okihara K, Yorozu A, Saito S, Tanaka N, Koga H, Higashide S et al (2017) Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: analysis from the Japanese prostate cancer outcome study of permanent iodine-125 seed implantation database. Int J Urol 24:518–524PubMed
24.
Zurück zum Zitat Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Montoye HJ, Sallis JF et al (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25:71–80PubMed Ainsworth BE, Haskell WL, Leon AS, Jacobs DR, Montoye HJ, Sallis JF et al (1993) Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25:71–80PubMed
25.
Zurück zum Zitat Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 306:1437–1440PubMedPubMedCentral Jenkinson C, Coulter A, Wright L (1993) Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 306:1437–1440PubMedPubMedCentral
26.
Zurück zum Zitat Matsukawa Y, Majima T, Matsuo K, Funahashi Y, Kato M, Yamamoto T et al (2018) Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study. Int J Urol 25:246–250PubMed Matsukawa Y, Majima T, Matsuo K, Funahashi Y, Kato M, Yamamoto T et al (2018) Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study. Int J Urol 25:246–250PubMed
27.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992PubMed Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982–992PubMed
28.
Zurück zum Zitat Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326PubMed Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326PubMed
29.
Zurück zum Zitat Eiko T, Minoru Y, Toshio N, Hideki Y (2009) Relation between the desire to the treatment of erectile dysfunction and IIEF5 score. Kenko Igaku 19:556–559 Eiko T, Minoru Y, Toshio N, Hideki Y (2009) Relation between the desire to the treatment of erectile dysfunction and IIEF5 score. Kenko Igaku 19:556–559
30.
Zurück zum Zitat Nagashima K, Hisada T, Sato M, Mochizuki J (2003) Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 69:1251–1262PubMedPubMedCentral Nagashima K, Hisada T, Sato M, Mochizuki J (2003) Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 69:1251–1262PubMedPubMedCentral
31.
Zurück zum Zitat Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M (2014) Development of a prokaryotic universal primer for simultaneous analysis of bacteria and Archaea using next-generation sequencing. Bourtzis K editor. PLoS ONE 9:e105592PubMedPubMedCentral Takahashi S, Tomita J, Nishioka K, Hisada T, Nishijima M (2014) Development of a prokaryotic universal primer for simultaneous analysis of bacteria and Archaea using next-generation sequencing. Bourtzis K editor. PLoS ONE 9:e105592PubMedPubMedCentral
32.
Zurück zum Zitat Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458PubMed Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458PubMed
33.
Zurück zum Zitat Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS et al (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12:R60PubMedPubMedCentral Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS et al (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12:R60PubMedPubMedCentral
34.
Zurück zum Zitat Maeda J, Nishida M, Takikawa H, Yoshida H, Azuma T, Yoshida M et al (2010) Inhibitory effects of sulfobacin B on DNA polymerase and inflammation. Int J Mol Med 26:751–758PubMed Maeda J, Nishida M, Takikawa H, Yoshida H, Azuma T, Yoshida M et al (2010) Inhibitory effects of sulfobacin B on DNA polymerase and inflammation. Int J Mol Med 26:751–758PubMed
35.
Zurück zum Zitat Kamiyama T, Umino T, Satoh T, Sawairi S, Shirane M, Ohshima S et al (1995) Sulfobacins A and B, novel von Willebrand factor receptor antagonists. I. Production, isolation, characterization and biological activities. J Antibiot (Tokyo) 48:924–928 Kamiyama T, Umino T, Satoh T, Sawairi S, Shirane M, Ohshima S et al (1995) Sulfobacins A and B, novel von Willebrand factor receptor antagonists. I. Production, isolation, characterization and biological activities. J Antibiot (Tokyo) 48:924–928
36.
Zurück zum Zitat Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C (2007) Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 52:1590–1600PubMed Vlachopoulos C, Rokkas K, Ioakeimidis N, Stefanadis C (2007) Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links. Eur Urol 52:1590–1600PubMed
37.
Zurück zum Zitat Jie Z, Xia H, Zhong S-L, Feng Q, Li S, Liang S et al (2017) The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 8:845PubMedPubMedCentral Jie Z, Xia H, Zhong S-L, Feng Q, Li S, Liang S et al (2017) The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 8:845PubMedPubMedCentral
38.
Zurück zum Zitat Shimozato A, Sasaki M, Ogasawara N, Funaki Y, Ebi M, Goto C et al (2017) Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: a preliminary randomized double-blind, placebo-controlled study. United Eur Gastroenterol J 5:898–907 Shimozato A, Sasaki M, Ogasawara N, Funaki Y, Ebi M, Goto C et al (2017) Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: a preliminary randomized double-blind, placebo-controlled study. United Eur Gastroenterol J 5:898–907
39.
Zurück zum Zitat Rajilić-Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S et al (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141:1792–1801PubMed Rajilić-Stojanović M, Biagi E, Heilig HGHJ, Kajander K, Kekkonen RA, Tims S et al (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141:1792–1801PubMed
40.
Zurück zum Zitat Hsu C-Y, Lin C-L, Kao C-H (2015) Irritable bowel syndrome is associated not only with organic but also psychogenic erectile dysfunction. Int J Impot Res 27:233–238PubMed Hsu C-Y, Lin C-L, Kao C-H (2015) Irritable bowel syndrome is associated not only with organic but also psychogenic erectile dysfunction. Int J Impot Res 27:233–238PubMed
41.
Zurück zum Zitat Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500:232–236PubMed Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H et al (2013) Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500:232–236PubMed
42.
Zurück zum Zitat Gonzalez-Sanchez B, Cendejas-Gomez J, Alejandro Rivera-Ramirez J, Herrera-Caceres JO, Olvera-Posada D, Villeda-Sandoval CI et al (2016) The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS). World J Urol 34:979–983PubMed Gonzalez-Sanchez B, Cendejas-Gomez J, Alejandro Rivera-Ramirez J, Herrera-Caceres JO, Olvera-Posada D, Villeda-Sandoval CI et al (2016) The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS). World J Urol 34:979–983PubMed
43.
Zurück zum Zitat Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S et al (2019) Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan. BJU Int 123:877–884PubMed Matsumoto T, Hatakeyama S, Imai A, Tanaka T, Hagiwara K, Konishi S et al (2019) Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan. BJU Int 123:877–884PubMed
44.
Zurück zum Zitat Soma O, Hatakeyama S, Imai A, Matsumoto T, Hamano I, Fujita N, et al. (2019). Relationship between frailty and lower urinary tract symptoms among community‐dwelling adults. LUTS Low Urin Tract Symptoms. :luts.12292. Soma O, Hatakeyama S, Imai A, Matsumoto T, Hamano I, Fujita N, et al. (2019). Relationship between frailty and lower urinary tract symptoms among community‐dwelling adults. LUTS Low Urin Tract Symptoms. :luts.12292.
Metadaten
Titel
The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan
verfasst von
Teppei Okamoto
Shingo Hatakeyama
Atsushi Imai
Hayato Yamamoto
Tohru Yoneyama
Kazuyuki Mori
Takahiro Yoneyama
Yasuhiro Hashimoto
Shigeyuki Nakaji
Chikara Ohyama
Publikationsdatum
19.03.2020
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 8/2020
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02443-9

Weitere Artikel der Ausgabe 8/2020

International Urology and Nephrology 8/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.